Strikingly, the cognitive deficits seen in a mouse model of Huntington's disease (R6/1) can be rescued by the antipsychotic drug fluoxetine, a potent inhibitor of phosphodiesterase type IV (PDE4A, B, C and D) [21]. The gene discussed is PDE4A; the disease is juvenile Huntington disease.